These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20447827)

  • 1. Characterization of 4-methyl-2-oxo-1,2-dihydroquinolin-6-yl acetate as an effective antiplatelet agent.
    Priya N; Gupta A; Chand K; Singh P; Kathuria A; Raj HG; Parmar VS; Sharma SK
    Bioorg Med Chem; 2010 Jun; 18(11):4085-94. PubMed ID: 20447827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity of acetoxy derivatives of coumarins and quinolones towards Calreticulin mediated transacetylation: investigations on antiplatelet function.
    Kathuria A; Priya N; Chand K; Singh P; Gupta A; Jalal S; Gupta S; Raj HG; Sharma SK
    Bioorg Med Chem; 2012 Feb; 20(4):1624-38. PubMed ID: 22264757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of calreticulin transacetylase to acetoxy derivatives of benzofurans: effect on the activation of platelet nitric oxide synthase.
    Gupta A; Priya N; Jalal S; Singh P; Chand K; Raj HG; Parmar VS; DePass AL; Sharma SK
    Biochimie; 2010 Sep; 92(9):1180-5. PubMed ID: 20600569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificities of calreticulin transacetylase to acetoxy derivatives of 3-alkyl-4-methylcoumarins: effect on the activation of nitric oxide synthase.
    Kathuria A; Gupta A; Priya N; Singh P; Raj HG; Prasad AK; Parmar VS; Sharma SK
    Bioorg Med Chem; 2009 Feb; 17(4):1550-6. PubMed ID: 19181531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
    Kumar A; Sushama A; Manral S; Sinha R; Joshi R; Singh U; Rohil V; Prasad AK; Parmar VS; Raj HG
    Nitric Oxide; 2012 Jan; 26(1):9-19. PubMed ID: 22100620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calreticulin transacetylase: a novel enzyme-mediated protein acetylation by acetoxy derivatives of 3-alkyl-4-methylcoumarins.
    Jalal S; Chand K; Kathuria A; Singh P; Priya N; Gupta B; Raj HG; Sharma SK
    Bioorg Chem; 2012 Feb; 40(1):131-136. PubMed ID: 22130072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetoxy drug: protein transacetylase catalyzed activation of human platelet nitric oxide synthase by polyphenolic peracetates.
    Khurana P; Kumari R; Vohra P; Kumar A; Seema ; Gupta G; Raj HG; Dwarakanath BS; Parmar VS; Saluja D; Bose M; Vij A; Chaudhary NK; Adhikari JS; Tyagi YK; Kohli E
    Bioorg Med Chem; 2006 Jan; 14(2):575-83. PubMed ID: 16214347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calreticulin transacylase: genesis, mechanism of action and biological applications.
    Kumari R; Bansal S; Gupta G; Arora S; Kumar A; Goel S; Singh P; Ponnan P; Priya N; Tyagi TK; Baghel AS; Manral S; Tandon R; Joshi R; Rohil V; Gaspari M; Kohli E; Tyagi YK; Dwarakanath BS; Saluja D; Chatterji S; Sharma SK; Prasad AK; Rastogi RC; Raj HG; Parmar VS
    Biochimie; 2010 Sep; 92(9):1173-9. PubMed ID: 20109516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calreticulin transacetylase mediates the acetylation of nitric oxide synthase by polyphenolic acetate.
    Bansal S; Gaspari M; Raj HG; Kumar A; Cuda G; Verheij E; Tyagi YK; Ponnan P; Rastogi RC; Parmar VS
    Appl Biochem Biotechnol; 2008 Jan; 144(1):37-45. PubMed ID: 18415985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
    Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
    J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calreticulin transacetylase in the activation of human platelet nitrite reductase by polyphenolic acetates.
    Arora S; Tyagi YK; Kumar A; Majumder S; Saluja D; Raj HG; Chatterjee S; Saso L; Prasad AK; Parmar VS
    Biol Pharm Bull; 2009 Feb; 32(2):161-5. PubMed ID: 19182369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity.
    Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS
    J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calreticulin transacetylase catalyzed modification of the TNF-alpha mediated pathway in the human peripheral blood mononuclear cells by polyphenolic acetates.
    Singh U; Kumar A; Sinha R; Manral S; Arora S; Ram S; Mishra RK; Gupta P; Bansal SK; Prasad AK; Biswal S; Parmar VS; Raj HG
    Chem Biol Interact; 2010 May; 185(3):263-70. PubMed ID: 20188080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet effect of a new inhibitor of thromboxane synthase and thromboxane A2 receptors.
    Tubaro E; Belogi L; Mezzadri CM
    Arzneimittelforschung; 1996 Jan; 46(1):35-41. PubMed ID: 8821515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
    Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
    Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production.
    Lechi C; Andrioli G; Gaino S; Tommasoli R; Zuliani V; Ortolani R; Degan M; Benoni G; Bellavite P; Lechi A; Minuz P
    Thromb Haemost; 1996 Nov; 76(5):791-8. PubMed ID: 8950792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antiproliferative, and antiplatelet activities of oxime- and amide-containing quinolin-2(1H)-one derivatives.
    Chen IL; Chang KM; Miaw CL; Liao CH; Chen JJ; Wang TC
    Bioorg Med Chem; 2007 Oct; 15(20):6527-34. PubMed ID: 17689252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.